Ponoi Management, LLC
- SEC CIK
- 0001720702
- Latest filing
- Nov 14, 2022
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 4
- 0 vs. Q1 2022
- Portfolio value
- $63.3M
- −$13.7M (−17.8%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RAPTRAPT Therapeutics, Inc. | COM | 1,599,417 | $29.2M | 46.1% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 1,298,908 | $16.7M | 26.3% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 685,011 | $13.4M | 21.1% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 327,123 | $4.14M | 6.5% | +10.0% | Added | History |